首页> 外文期刊>Trakya Universitesi. Tip Fakultesi Dergisi. >Scleredema Diabeticorum Partially Treated with Low-Dose Methotrexate: a Report of Five Cases
【24h】

Scleredema Diabeticorum Partially Treated with Low-Dose Methotrexate: a Report of Five Cases

机译:小剂量甲氨蝶呤部分治疗糖尿病性巩膜水肿5例报告

获取原文
           

摘要

Scleredema is a rare connective tissue disorder that belongs to a group of scleroderma-like disorders. Although no known curative therapy exists, various specific treatments have been proposed in the literature. In this report, we describe five cases of scleredema partially treated with low-dose methotrexate therapy. All patients have diabetes mellitus type II. All patients were started on methotrexate 15 mg subcutaneously once weekly for 3 months. Biopsy specimens were taken from all patients and were examinated histologically before the treatment and after 3 months of treatment. All cases partially responded to low-dose methotrexate therapy. We believe that methotrexate therapy may be an alternative therapeutic options in scleredema in view of its efficacy.
机译:巩膜水肿是一种罕见的结缔组织疾病,属于一组硬皮病样疾病。尽管不存在已知的治疗方法,但是文献中已经提出了各种具体治疗方法。在本报告中,我们描述了5例使用小剂量甲氨蝶呤疗法部分治疗的硬化性水肿。所有患者均患有II型糖尿病。所有患者每周一次皮下注射甲氨蝶呤15 mg,持续3个月。从所有患者中获取活检标本,并在治疗前和治疗3个月后进行组织学检查。所有病例均对低剂量甲氨蝶呤治疗有反应。鉴于其功效,我们认为甲氨蝶呤疗法可能是硬化性水肿的替代治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号